blu-945
blueprint medicines,roche
['blu-945', 'lcsm,(-blcsm)', 'symphony', 'nsclc', 'sclc']
blu-945, 4th generation egfr tki, in egfr-mutant nsclc well tolerated but response was not durable due to genomic heterogeneity data from phase 1/2 symphony study #asco23 #lcsm 
MD PhD, lung oncologist & researcher @IEOufficiale; @myESMO Communication Committee Chair; #LungCancer Molecular target-believer #LCSM